Literature DB >> 16573772

Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflammation: are they all the same?

Sandeep K Gupta1, Marc Peters-Golden, Joseph F Fitzgerald, Joseph M Croffie, Marian D Pfefferkorn, Jean P Molleston, Mark R Corkins, Joel R Lim.   

Abstract

OBJECTIVES: Allergic eosinophilic esophagitis (AEE) is characterized by intense eosinophilic inflammation of the esophageal mucosa. Cysteinyl leukotrienes (CysLT) are eosinophil chemoattractants. We studied CysLT levels in esophageal mucosa of children with AEE and controls.
METHODS: CysLT levels (pg CysLT/microg protein) were quantified by Enzyme-linked Immunosorbent Assay (ELISA) on endoscopically obtained esophageal mucosal biopsies.
RESULTS: Twelve children with AEE (eight boys, mean age 6.6 yr, range 1.0-14.5 yr) and 10 controls (six boys, mean age 9.56 yr, range 1.08-15.08 yr) were enrolled. None were on anti-LT or corticosteroid therapy. All controls had histologically normal mucosal biopsies of the esophagus, stomach, and duodenum. Patients with AEE had intense eosinophilic inflammation of the esophageal mucosa (mean 39 eosinophils/hpf, range 15-70 eosinophils/hpf) and a normal 24-h pH probe study. CysLT levels were similar between the two groups: mean levels were 12.44 (median 10.87, range 2.54-28.29) in AEE patients and 9.52 (median 9.26, range 1.71-21.64) in controls. CysLT levels did not correlate with the degree of esophageal eosinophilic inflammation. Incidentally, five patients with eosinophilic gastroduodenitis, in addition to esophagitis, were enrolled; their CysLT levels were statistically higher than those of controls.
CONCLUSIONS: This is the first study to examine CysLT levels in esophageal mucosal biopsies of children with AEE and normal children. CysLT levels in AEE patients are similar to those in controls, and independent of the severity of inflammation. While this would argue against the use of CysLT antagonists in the treatment of AEE, further studies into the expression of the CysLT receptor itself are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573772     DOI: 10.1111/j.1572-0241.2006.00557.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  19 in total

1.  Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis.

Authors:  Levent Filik
Journal:  Dig Dis Sci       Date:  2012-01       Impact factor: 3.199

Review 2.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

3.  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 4.  Allergic eosinophilic esophagitis.

Authors:  Kevin C Bax; Sandeep K Gupta
Journal:  Indian J Pediatr       Date:  2006-10       Impact factor: 1.967

Review 5.  Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.

Authors:  Swathi Eluri; Evan S Dellon
Journal:  Curr Opin Gastroenterol       Date:  2015-07       Impact factor: 3.287

6.  Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.

Authors:  Alfredo J Lucendo; Livia C De Rezende; Susana Jiménez-Contreras; Jose Luis Yagüe-Compadre; Jesús González-Cervera; Teresa Mota-Huertas; Danila Guagnozzi; Teresa Angueira; Sonia González-Castillo; Angel Arias
Journal:  Dig Dis Sci       Date:  2011-06-15       Impact factor: 3.199

7.  Elevated levels of leukotriene C4 synthase mRNA distinguish a subpopulation of eosinophilic oesophagitis patients.

Authors:  W S Lexmond; M Pardo; K Rooney; J A Goettel; S B Snapper; E H Yen; E Dehlink; S Nurko; E Fiebiger
Journal:  Clin Exp Allergy       Date:  2013-08       Impact factor: 5.018

Review 8.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

Review 9.  Chemotactic factors associated with eosinophilic gastrointestinal diseases.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

10.  Eosinophilic Esophagitis: update on treatment approaches.

Authors:  L Fotis; M Xatzipsalti; A Papadopoulou
Journal:  Hippokratia       Date:  2012-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.